ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Parenteral Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-18G7535
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Parenteral Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Parenteral Drugs Market Research Report 2025

Code: QYRE-Auto-18G7535
Report
September 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
SSY Group
Cisen

Parenteral Drugs Market Size

The global market for Parenteral Drugs was valued at US$ 16810 million in the year 2024 and is projected to reach a revised size of US$ 22180 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Parenteral Drugs Market

Parenteral Drugs Market

Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a "catch-all" for all non-LVP parenterals products except biologicals.
The global pharmaceutical market is approximately $1.47 trillion, with a CAGR of approximately 5% expected over the next six years. The pharmaceutical market includes chemical drugs and biological drugs.
The driving factors of the pharmaceutical market mainly include: increased demand for healthcare, advances in pharmaceutical technology and rising prevalence of chronic diseases, and increased pharmaceutical R&D activities and investments. However, the industry also faces various challenges such as strict market regulation, high R&D costs, expiration of drug patents, and declining revenues. Companies need to continue to innovate and adapt to these challenges to remain competitive in the market. In addition, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to respond flexibly to emerging public health needs.
As the global population aging trend intensifies, the proportion of the elderly population is increasing year by year. This group of people is more susceptible to chronic diseases, which often require long-term treatment and may be accompanied by insufficient nutritional intake. Parenteral drugs, especially parenteral nutrition drugs, provide important nutritional support and treatment for these patients.
Increased medical demand: The demand for medical services among the elderly population has increased significantly, especially the patient group that requires parenteral nutrition support and treatment, which has further promoted the development of the parenteral drug market.
Rising incidence of chronic diseases: With the change of lifestyle and the aggravation of environmental pollution, the incidence of chronic diseases has increased year by year. These chronic diseases, such as diabetes, cardiovascular disease, kidney disease, etc., usually require long-term treatment and may be accompanied by insufficient nutritional intake.
Demand for parenteral drug treatment: Parenteral drugs provide effective treatment for these chronic disease patients and meet their treatment needs, thereby promoting the development of the parenteral drug market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Parenteral Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parenteral Drugs.
The Parenteral Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parenteral Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parenteral Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Parenteral Drugs Market Report

Report Metric Details
Report Name Parenteral Drugs Market
Accounted market size in year US$ 16810 million
Forecasted market size in 2031 US$ 22180 million
CAGR 4.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Medical Centers
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ostuka Pharmaceutical, Teva Pharmaceutical Industries, Kelun Pharma, Cook Pharmica, Patheon, BAG Healthcare, Beximco Pharma, Baxter Healthcare Corporation, B. Braun, Fresenius, Albert David, BML Parenteral Drugs, Pfizer (Hospira), SSY Group, Ozon Pharmaceuticals Ltd, Aspen Holdings, PSI Ltd, Cisen, AXA Parenterals Ltd, Acebright, Southwest Pharmaceutical, Abbott
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Parenteral Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Parenteral Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Parenteral Drugs Market growing?

Ans: The Parenteral Drugs Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Parenteral Drugs Market size in 2031?

Ans: The Parenteral Drugs Market size in 2031 will be US$ 22180 million.

Who are the main players in the Parenteral Drugs Market report?

Ans: The main players in the Parenteral Drugs Market are Ostuka Pharmaceutical, Teva Pharmaceutical Industries, Kelun Pharma, Cook Pharmica, Patheon, BAG Healthcare, Beximco Pharma, Baxter Healthcare Corporation, B. Braun, Fresenius, Albert David, BML Parenteral Drugs, Pfizer (Hospira), SSY Group, Ozon Pharmaceuticals Ltd, Aspen Holdings, PSI Ltd, Cisen, AXA Parenterals Ltd, Acebright, Southwest Pharmaceutical, Abbott

What are the Application segmentation covered in the Parenteral Drugs Market report?

Ans: The Applications covered in the Parenteral Drugs Market report are Hospitals, Medical Centers, Others

What are the Type segmentation covered in the Parenteral Drugs Market report?

Ans: The Types covered in the Parenteral Drugs Market report are LVP Drug, SVP Drug

Recommended Reports

Parenteral Nutrition & Infusion

Therapeutic Drug Markets

Medical Packaging Solutions

1 Parenteral Drugs Market Overview
1.1 Product Definition
1.2 Parenteral Drugs by Type
1.2.1 Global Parenteral Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs by Application
1.3.1 Global Parenteral Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Global Parenteral Drugs Market Size Estimates and Forecasts
1.4.1 Global Parenteral Drugs Revenue 2020-2031
1.4.2 Global Parenteral Drugs Sales 2020-2031
1.4.3 Global Parenteral Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Parenteral Drugs Market Competition by Manufacturers
2.1 Global Parenteral Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Parenteral Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Parenteral Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Parenteral Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Drugs, Product Type & Application
2.7 Global Key Manufacturers of Parenteral Drugs, Date of Enter into This Industry
2.8 Global Parenteral Drugs Market Competitive Situation and Trends
2.8.1 Global Parenteral Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Parenteral Drugs Players Market Share by Revenue
2.8.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Parenteral Drugs Market Scenario by Region
3.1 Global Parenteral Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Parenteral Drugs Sales by Region: 2020-2031
3.2.1 Global Parenteral Drugs Sales by Region: 2020-2025
3.2.2 Global Parenteral Drugs Sales by Region: 2026-2031
3.3 Global Parenteral Drugs Revenue by Region: 2020-2031
3.3.1 Global Parenteral Drugs Revenue by Region: 2020-2025
3.3.2 Global Parenteral Drugs Revenue by Region: 2026-2031
3.4 North America Parenteral Drugs Market Facts & Figures by Country
3.4.1 North America Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Parenteral Drugs Sales by Country (2020-2031)
3.4.3 North America Parenteral Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.4.6 Mexico
3.5 Europe Parenteral Drugs Market Facts & Figures by Country
3.5.1 Europe Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Parenteral Drugs Sales by Country (2020-2031)
3.5.3 Europe Parenteral Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Parenteral Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Parenteral Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Parenteral Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Parenteral Drugs Market Facts & Figures by Country
3.7.1 Latin America Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Parenteral Drugs Sales by Country (2020-2031)
3.7.3 Latin America Parenteral Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Parenteral Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Parenteral Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Parenteral Drugs Sales by Type (2020-2031)
4.1.1 Global Parenteral Drugs Sales by Type (2020-2025)
4.1.2 Global Parenteral Drugs Sales by Type (2026-2031)
4.1.3 Global Parenteral Drugs Sales Market Share by Type (2020-2031)
4.2 Global Parenteral Drugs Revenue by Type (2020-2031)
4.2.1 Global Parenteral Drugs Revenue by Type (2020-2025)
4.2.2 Global Parenteral Drugs Revenue by Type (2026-2031)
4.2.3 Global Parenteral Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Parenteral Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Parenteral Drugs Sales by Application (2020-2031)
5.1.1 Global Parenteral Drugs Sales by Application (2020-2025)
5.1.2 Global Parenteral Drugs Sales by Application (2026-2031)
5.1.3 Global Parenteral Drugs Sales Market Share by Application (2020-2031)
5.2 Global Parenteral Drugs Revenue by Application (2020-2031)
5.2.1 Global Parenteral Drugs Revenue by Application (2020-2025)
5.2.2 Global Parenteral Drugs Revenue by Application (2026-2031)
5.2.3 Global Parenteral Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Parenteral Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ostuka Pharmaceutical
6.1.1 Ostuka Pharmaceutical Company Information
6.1.2 Ostuka Pharmaceutical Description and Business Overview
6.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ostuka Pharmaceutical Parenteral Drugs Product Portfolio
6.1.5 Ostuka Pharmaceutical Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Company Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceutical Industries Parenteral Drugs Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 Kelun Pharma
6.3.1 Kelun Pharma Company Information
6.3.2 Kelun Pharma Description and Business Overview
6.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Kelun Pharma Parenteral Drugs Product Portfolio
6.3.5 Kelun Pharma Recent Developments/Updates
6.4 Cook Pharmica
6.4.1 Cook Pharmica Company Information
6.4.2 Cook Pharmica Description and Business Overview
6.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cook Pharmica Parenteral Drugs Product Portfolio
6.4.5 Cook Pharmica Recent Developments/Updates
6.5 Patheon
6.5.1 Patheon Company Information
6.5.2 Patheon Description and Business Overview
6.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Patheon Parenteral Drugs Product Portfolio
6.5.5 Patheon Recent Developments/Updates
6.6 BAG Healthcare
6.6.1 BAG Healthcare Company Information
6.6.2 BAG Healthcare Description and Business Overview
6.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BAG Healthcare Parenteral Drugs Product Portfolio
6.6.5 BAG Healthcare Recent Developments/Updates
6.7 Beximco Pharma
6.7.1 Beximco Pharma Company Information
6.7.2 Beximco Pharma Description and Business Overview
6.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Beximco Pharma Parenteral Drugs Product Portfolio
6.7.5 Beximco Pharma Recent Developments/Updates
6.8 Baxter Healthcare Corporation
6.8.1 Baxter Healthcare Corporation Company Information
6.8.2 Baxter Healthcare Corporation Description and Business Overview
6.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Baxter Healthcare Corporation Parenteral Drugs Product Portfolio
6.8.5 Baxter Healthcare Corporation Recent Developments/Updates
6.9 B. Braun
6.9.1 B. Braun Company Information
6.9.2 B. Braun Description and Business Overview
6.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 B. Braun Parenteral Drugs Product Portfolio
6.9.5 B. Braun Recent Developments/Updates
6.10 Fresenius
6.10.1 Fresenius Company Information
6.10.2 Fresenius Description and Business Overview
6.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Fresenius Parenteral Drugs Product Portfolio
6.10.5 Fresenius Recent Developments/Updates
6.11 Albert David
6.11.1 Albert David Company Information
6.11.2 Albert David Description and Business Overview
6.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Albert David Parenteral Drugs Product Portfolio
6.11.5 Albert David Recent Developments/Updates
6.12 BML Parenteral Drugs
6.12.1 BML Parenteral Drugs Company Information
6.12.2 BML Parenteral Drugs Description and Business Overview
6.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BML Parenteral Drugs Parenteral Drugs Product Portfolio
6.12.5 BML Parenteral Drugs Recent Developments/Updates
6.13 Pfizer (Hospira)
6.13.1 Pfizer (Hospira) Company Information
6.13.2 Pfizer (Hospira) Description and Business Overview
6.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Pfizer (Hospira) Parenteral Drugs Product Portfolio
6.13.5 Pfizer (Hospira) Recent Developments/Updates
6.14 SSY Group
6.14.1 SSY Group Company Information
6.14.2 SSY Group Description and Business Overview
6.14.3 SSY Group Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 SSY Group Parenteral Drugs Product Portfolio
6.14.5 SSY Group Recent Developments/Updates
6.15 Ozon Pharmaceuticals Ltd
6.15.1 Ozon Pharmaceuticals Ltd Company Information
6.15.2 Ozon Pharmaceuticals Ltd Description and Business Overview
6.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Product Portfolio
6.15.5 Ozon Pharmaceuticals Ltd Recent Developments/Updates
6.16 Aspen Holdings
6.16.1 Aspen Holdings Company Information
6.16.2 Aspen Holdings Description and Business Overview
6.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Aspen Holdings Parenteral Drugs Product Portfolio
6.16.5 Aspen Holdings Recent Developments/Updates
6.17 PSI Ltd
6.17.1 PSI Ltd Company Information
6.17.2 PSI Ltd Description and Business Overview
6.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 PSI Ltd Parenteral Drugs Product Portfolio
6.17.5 PSI Ltd Recent Developments/Updates
6.18 Cisen
6.18.1 Cisen Company Information
6.18.2 Cisen Description and Business Overview
6.18.3 Cisen Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Cisen Parenteral Drugs Product Portfolio
6.18.5 Cisen Recent Developments/Updates
6.19 AXA Parenterals Ltd
6.19.1 AXA Parenterals Ltd Company Information
6.19.2 AXA Parenterals Ltd Description and Business Overview
6.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 AXA Parenterals Ltd Parenteral Drugs Product Portfolio
6.19.5 AXA Parenterals Ltd Recent Developments/Updates
6.20 Acebright
6.20.1 Acebright Company Information
6.20.2 Acebright Description and Business Overview
6.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Acebright Parenteral Drugs Product Portfolio
6.20.5 Acebright Recent Developments/Updates
6.21 Southwest Pharmaceutical
6.21.1 Southwest Pharmaceutical Company Information
6.21.2 Southwest Pharmaceutical Description and Business Overview
6.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Southwest Pharmaceutical Parenteral Drugs Product Portfolio
6.21.5 Southwest Pharmaceutical Recent Developments/Updates
6.22 Abbott
6.22.1 Abbott Company Information
6.22.2 Abbott Description and Business Overview
6.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Abbott Parenteral Drugs Product Portfolio
6.22.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Drugs Industry Chain Analysis
7.2 Parenteral Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Drugs Production Mode & Process Analysis
7.4 Parenteral Drugs Sales and Marketing
7.4.1 Parenteral Drugs Sales Channels
7.4.2 Parenteral Drugs Distributors
7.5 Parenteral Drugs Customer Analysis
8 Parenteral Drugs Market Dynamics
8.1 Parenteral Drugs Industry Trends
8.2 Parenteral Drugs Market Drivers
8.3 Parenteral Drugs Market Challenges
8.4 Parenteral Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
SSY Group
Cisen
List of Tables
 Table 1. Global Parenteral Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Parenteral Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Parenteral Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Parenteral Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Parenteral Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Parenteral Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Parenteral Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Parenteral Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Parenteral Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Parenteral Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Parenteral Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Parenteral Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Parenteral Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parenteral Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Parenteral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Parenteral Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Parenteral Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Parenteral Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Parenteral Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Parenteral Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Parenteral Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Parenteral Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Parenteral Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Parenteral Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Parenteral Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Parenteral Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Parenteral Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Parenteral Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Parenteral Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Parenteral Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Parenteral Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Parenteral Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Parenteral Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Parenteral Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Parenteral Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Parenteral Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Parenteral Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Parenteral Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Parenteral Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Parenteral Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Parenteral Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Parenteral Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Parenteral Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Parenteral Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Parenteral Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Parenteral Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Parenteral Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Parenteral Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Parenteral Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Parenteral Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Parenteral Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Parenteral Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Parenteral Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Parenteral Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Parenteral Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Parenteral Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Parenteral Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Parenteral Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Parenteral Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Ostuka Pharmaceutical Company Information
 Table 71. Ostuka Pharmaceutical Description and Business Overview
 Table 72. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Ostuka Pharmaceutical Parenteral Drugs Product
 Table 74. Ostuka Pharmaceutical Recent Developments/Updates
 Table 75. Teva Pharmaceutical Industries Company Information
 Table 76. Teva Pharmaceutical Industries Description and Business Overview
 Table 77. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceutical Industries Parenteral Drugs Product
 Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 80. Kelun Pharma Company Information
 Table 81. Kelun Pharma Description and Business Overview
 Table 82. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Kelun Pharma Parenteral Drugs Product
 Table 84. Kelun Pharma Recent Developments/Updates
 Table 85. Cook Pharmica Company Information
 Table 86. Cook Pharmica Description and Business Overview
 Table 87. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Cook Pharmica Parenteral Drugs Product
 Table 89. Cook Pharmica Recent Developments/Updates
 Table 90. Patheon Company Information
 Table 91. Patheon Description and Business Overview
 Table 92. Patheon Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Patheon Parenteral Drugs Product
 Table 94. Patheon Recent Developments/Updates
 Table 95. BAG Healthcare Company Information
 Table 96. BAG Healthcare Description and Business Overview
 Table 97. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. BAG Healthcare Parenteral Drugs Product
 Table 99. BAG Healthcare Recent Developments/Updates
 Table 100. Beximco Pharma Company Information
 Table 101. Beximco Pharma Description and Business Overview
 Table 102. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Beximco Pharma Parenteral Drugs Product
 Table 104. Beximco Pharma Recent Developments/Updates
 Table 105. Baxter Healthcare Corporation Company Information
 Table 106. Baxter Healthcare Corporation Description and Business Overview
 Table 107. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Baxter Healthcare Corporation Parenteral Drugs Product
 Table 109. Baxter Healthcare Corporation Recent Developments/Updates
 Table 110. B. Braun Company Information
 Table 111. B. Braun Description and Business Overview
 Table 112. B. Braun Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. B. Braun Parenteral Drugs Product
 Table 114. B. Braun Recent Developments/Updates
 Table 115. Fresenius Company Information
 Table 116. Fresenius Description and Business Overview
 Table 117. Fresenius Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Fresenius Parenteral Drugs Product
 Table 119. Fresenius Recent Developments/Updates
 Table 120. Albert David Company Information
 Table 121. Albert David Description and Business Overview
 Table 122. Albert David Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Albert David Parenteral Drugs Product
 Table 124. Albert David Recent Developments/Updates
 Table 125. BML Parenteral Drugs Company Information
 Table 126. BML Parenteral Drugs Description and Business Overview
 Table 127. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. BML Parenteral Drugs Parenteral Drugs Product
 Table 129. BML Parenteral Drugs Recent Developments/Updates
 Table 130. Pfizer (Hospira) Company Information
 Table 131. Pfizer (Hospira) Description and Business Overview
 Table 132. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Pfizer (Hospira) Parenteral Drugs Product
 Table 134. Pfizer (Hospira) Recent Developments/Updates
 Table 135. SSY Group Company Information
 Table 136. SSY Group Description and Business Overview
 Table 137. SSY Group Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. SSY Group Parenteral Drugs Product
 Table 139. SSY Group Recent Developments/Updates
 Table 140. Ozon Pharmaceuticals Ltd Company Information
 Table 141. Ozon Pharmaceuticals Ltd Description and Business Overview
 Table 142. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Ozon Pharmaceuticals Ltd Parenteral Drugs Product
 Table 144. Ozon Pharmaceuticals Ltd Recent Developments/Updates
 Table 145. Aspen Holdings Company Information
 Table 146. Aspen Holdings Description and Business Overview
 Table 147. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Aspen Holdings Parenteral Drugs Product
 Table 149. Aspen Holdings Recent Developments/Updates
 Table 150. PSI Ltd Company Information
 Table 151. PSI Ltd Description and Business Overview
 Table 152. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. PSI Ltd Parenteral Drugs Product
 Table 154. PSI Ltd Recent Developments/Updates
 Table 155. Cisen Company Information
 Table 156. Cisen Description and Business Overview
 Table 157. Cisen Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 158. Cisen Parenteral Drugs Product
 Table 159. Cisen Recent Developments/Updates
 Table 160. AXA Parenterals Ltd Company Information
 Table 161. AXA Parenterals Ltd Description and Business Overview
 Table 162. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 163. AXA Parenterals Ltd Parenteral Drugs Product
 Table 164. AXA Parenterals Ltd Recent Developments/Updates
 Table 165. Acebright Company Information
 Table 166. Acebright Description and Business Overview
 Table 167. Acebright Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 168. Acebright Parenteral Drugs Product
 Table 169. Acebright Recent Developments/Updates
 Table 170. Southwest Pharmaceutical Company Information
 Table 171. Southwest Pharmaceutical Description and Business Overview
 Table 172. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 173. Southwest Pharmaceutical Parenteral Drugs Product
 Table 174. Southwest Pharmaceutical Recent Developments/Updates
 Table 175. Abbott Company Information
 Table 176. Abbott Description and Business Overview
 Table 177. Abbott Parenteral Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 178. Abbott Parenteral Drugs Product
 Table 179. Abbott Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Parenteral Drugs Distributors List
 Table 183. Parenteral Drugs Customers List
 Table 184. Parenteral Drugs Market Trends
 Table 185. Parenteral Drugs Market Drivers
 Table 186. Parenteral Drugs Market Challenges
 Table 187. Parenteral Drugs Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Parenteral Drugs
 Figure 2. Global Parenteral Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Parenteral Drugs Market Share by Type: 2024 & 2031
 Figure 4. LVP Drug Product Picture
 Figure 5. SVP Drug Product Picture
 Figure 6. Global Parenteral Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Parenteral Drugs Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Medical Centers
 Figure 10. Others
 Figure 11. Global Parenteral Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Parenteral Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Parenteral Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Parenteral Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 15. Parenteral Drugs Report Years Considered
 Figure 16. Parenteral Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Parenteral Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Parenteral Drugs Players: Market Share by Revenue in Parenteral Drugs in 2024
 Figure 19. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Parenteral Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Parenteral Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Parenteral Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Mexico Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Parenteral Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Parenteral Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Parenteral Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Parenteral Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Parenteral Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Parenteral Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Parenteral Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Parenteral Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Parenteral Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Parenteral Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Parenteral Drugs by Type (2020-2031)
 Figure 57. Global Parenteral Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Parenteral Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Parenteral Drugs by Application (2020-2031)
 Figure 60. Global Parenteral Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 61. Parenteral Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Large Volume Parenteral Product Market Research Report 2025
Global Large Volume Parenteral Preparations Market Research Report 2025
Global Large Volume Parenteral LVP Market Research Report 2024
Global Large Volume Parenteral Non PVC Bag Market Research Report 2025
Global Non LVP Parenterals Products Market Insights Forecast to 2030
Global Small Volume Parenterals SVP Market Insights Forecast to 2030
Global Parenteral Nutrition Preparation Market Research Report 2024
Global Total Parenteral Nutrition Preparation Market Research Report 2024
Global Human Parenteral Nutrition Market Research Report 2025
Large Volume Intravenous Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Total Parenteral Nutrition TPN Market Research Report 2024
Global Injectable Drug Delivery Market Research Report 2024
Implantable Drug Delivery Devices Market
Global Parenteral Packaging Market Research Report 2024
Global Parenteral Excipients Market Research Report 2025
Global Parenteral Formula Market Research Report 2024
Global Venous Infusion Set Market Research Report 2024
Global Intravenous Solutions Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Parenteral Products Packaging Market Research Report 2024
Global Sterile Injectable Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions